Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      One in five Covid-19 patients develop mental illness within 90 days - study
      Malaysiakini
      News
      One in five Covid-19 patients develop mental illness within 90 days - study

      One in five Covid-19 patients develop mental illness within 90 days - study

      ReutersPublished: Nov 10, 2020 10:48 PM | Updated: Nov 10, 2020 10:49 PM

      Many Covid-19 survivors are likely to be at greater risk of developing mental illness, psychiatrists said on Monday, after a large study found 20 percent of those infected with the coronavirus are diagnosed with a psychiatric disorder within 90 days.

      Anxiety, depression and insomnia were most common among recovered Covid-19 patients in the study who developed mental health problems. The researchers from Britain's Oxford University also found significantly higher risks of dementia, a brain impairment condition...

      Palestinian negotiator Erekat dies after contracting Covid-19

      Palestinian negotiator Erekat dies after contracting Covid-19

      Brazil suspends China’s Sinovac coronavirus vaccine trial

      Brazil suspends China’s Sinovac coronavirus vaccine trial

      BioNTech to price vaccine below market rates, differentiate between regions

      BioNTech to price vaccine below market rates, differentiate between regions

      Pfizer's Covid-19 vaccine: MOH to wait for clinical trial data

      Pfizer's Covid-19 vaccine: MOH to wait for clinical trial data

      Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

      Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports5

      Palestinian negotiator Erekat dies after contracting Covid-19

      05-07-2021

      Brazil suspends China’s Sinovac coronavirus vaccine trial

      10-11-2020

      BioNTech to price vaccine below market rates, differentiate between regions

      10-11-2020

      Pfizer's Covid-19 vaccine: MOH to wait for clinical trial data

      10-11-2020

      Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

      10-11-2020
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor